- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Arcadia Biosciences Inc (RKDA)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $12
1 Year Target Price $12
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -54.53% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.00M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 1 | Beta 0.48 | 52 Weeks Range 2.53 - 6.40 | Updated Date 12/14/2025 |
52 Weeks Range 2.53 - 6.40 | Updated Date 12/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -97.95% | Operating Margin (TTM) -88.48% |
Management Effectiveness
Return on Assets (TTM) -31.48% | Return on Equity (TTM) -64.65% |
Valuation
Trailing PE - | Forward PE 36.63 | Enterprise Value 566156 | Price to Sales(TTM) 0.97 |
Enterprise Value 566156 | Price to Sales(TTM) 0.97 | ||
Enterprise Value to Revenue 0.11 | Enterprise Value to EBITDA 0.62 | Shares Outstanding 1373120 | Shares Floating 1361902 |
Shares Outstanding 1373120 | Shares Floating 1361902 | ||
Percent Insiders 0.82 | Percent Institutions 4.77 |
About Arcadia Biosciences Inc
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2015-05-15 | CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director Mr. Thomas J. Schaefer C.F.A. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 9 | Website https://www.arcadiabio.com |
Full time employees 9 | Website https://www.arcadiabio.com | ||
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

